Please select the option that best describes you:
Topics:
Breast Cancer • Radiation Oncology
Does current data support use of intraoperative breast radiotherapy?
My institution is considering a major investment/purchase of this technology to complement our existing array of breast radiotherapy options.
Answer from: Radiation Oncologist at Academic Institution
I use the intrabeam IORT system and have treated about 90 patients. 22% have been given adjuvant whole breast or breast/axilla/scf xrt. The toxicity of IORT is significantly lower than other forms of APBI and external beam. The results of the Targit A trial support our experience in regards to toxic...
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
There are 3 major concerns with this approach:
Patients are selected for a treatment strategy without full pathological review of data
Dose to the target volume is not consistent with known radiobiology
The treatment does not allow for image-guided dose delivery (ie look up table dosimetry).
I...